Pathologist, Bordeaux University Hospital. Special interest in renal and transplant pathology.
Bordeaux, France
Joined September 2022
- Tweets60
- Following59
- Followers55
- Likes198
Bertrand Chauveau retweeted
The Banff 2024 meeting report is official! Link to the article (free access) is below- now get ready for the next Banff meeting, October 5-9, 2026, in beautiful Banff, Alberta, Canada!!
authors.elsevier.com/sd/arti… @Renalpathsoc #renalpath
Bertrand Chauveau retweeted
How many gene transcripts do you actually need to diagnose rejection phenotypes after kidney transplantation?
In our latest study in @KIReports, we found that the answer is surprisingly low!
kireports.org/article/S2468-…
1/6
Bertrand Chauveau retweeted
🧬Excited to share our new paper in @amjtransplant
“Molecular diagnosis of kidney allograft rejection using the B-HOT gene panel”
amjtransplant.org/article/S1…
#MolecularDiagnostics #Transplantation
Bertrand Chauveau retweeted
Evolving the Banff Classification for Kidney Allograft Rejection. This review paper by @_B_Chauveau et al. reports that innovations are reshaping rejection diagnostics! #Transplantation #KidneyTransplant #Transplantation #TXPforAll tinyurl.com/zh6m6wh6
Bertrand Chauveau retweeted
We now have a mass spectrometry test available for membranous nephropathy (MN) antigens.
Started in 2017 with no lab/funding (& still no lab/major funding)-one at a time-we were able to discover majority of MN antigens.
It was an idea that worked out.
news.mayocliniclabs.com/2025…
Bertrand Chauveau retweeted
Kidney-transplant microvascular inflammation has a varied clinical presentation. This study of more than 16,000 biopsy specimens supports the recognition of additional rejection phenotypes to standardize diagnostics. nej.md/4hiFoyJ
#KidneyWk
ALT A Sankey diagram of 4350 kidney-allograft biopsy specimens from patients with a diagnosis related to kidney-allograft rejection according to the 2022 Banff Classification of Renal Allograft Pathology.
Bertrand Chauveau retweeted
Dive into the #HORUS_CMV project with @hKminski, sharing insights on the team's efforts to understand #CMV's impact on transplant patients. Learn how they’re identifying signatures for personalised care to improve patient outcomes.
Watch the full video: horus-project.eu
Bertrand Chauveau retweeted
Glad to share our @EUTRAIN_project paper published in @Kidney_Int! 🙌
🙏 to the amazing #consortium behind this #biomarker validation study funded by @EU_Commission @HorizonEU 🇪🇺
@AlexandreLoupy C. Lefaucheur @ParisTxGroup @ESOTtransplant @ttsorg
kidney-international.org/art…
Bertrand Chauveau retweeted
Unveiling glomerular gold in oxalate nephropathy - Kidney International kidney-international.org/art…
Bertrand Chauveau retweeted
⚠️Happy to share our preliminary results on Imlifidase together with the French transplant community. 🙏🏻 @KamarNassim @dommibertrand @CaillardSophie @SFTfrancophone @SFTJuniors
More to come in 2025 🚨
kireports.org/article/S2468-…
Bertrand Chauveau retweeted
More on “atypical anti-GBM disease”! Worldwide collaborative by B Chauveau et al published in @AJKDonline doi.org/10.1053/j.ajkd.2023.… also see my commentary “Anti–GBM Disease: Broadening the Spectrum” doi.org/10.1053/j.ajkd.2024.… #renalpath @Renalpathsoc @MayoClinicNeph @MayoClinicPath
Bertrand Chauveau retweeted
Our study on post-transplant TMA is out! TMA is mostly driven by AMR and CNI toxicity but often due to multiple factors, with higher rates of complement pathogenic variants, and associated with a poor prognosis.
Original Article by Dessaix et al, "De novo thrombotic microangiopathy after kidney transplantation in adults: interplay between complement genetics and multiple endothelial injury"
doi.org/10.1016/j.ajt.2024.0…
Bertrand Chauveau retweeted
Finally, the Banff 2022 Meeting Report and Workplan manuscripts underwent standard peer review by @amjtransplant, before being accepted and published.
Importantly, it was decided that the Banff Meeting Report manuscript(s) are made Gold Open Access.
Bertrand Chauveau retweeted
QuPath v0.5.0 is now available!
Download it at qupath.github.io
See changes at github.com/qupath/qupath/blo…
This is a major update & the culmination of a busy few months for the @QuPath team...
More below👇
#opensource #bioimageanalysis #digitalpathology #javafx #microscopy
Bertrand Chauveau retweeted
🤔How can I measure non adherence after transplantation ?
✅ think about the immunosupressant Possession Ratio which Captures a Non-Adherence Associated With Antibody-Mediated Rejection frontierspartnerships.org/ar…
Bertrand Chauveau retweeted
A positive Congo red stain does not always indicate amyloidosis - rare cases can be Congophilic fibrillary glomerulopathy, confirm with DNAJB9 staining.
@GlomCon
Bertrand Chauveau retweeted
Do you want to know the Minimal Diagnostic Criteria for TMA?. Finally a consensus for the morphologic diagnosis of TMA frontierspartnerships.org/ar…
Bertrand Chauveau retweeted
Monitoring of kidney allograft using urinary chemokines becomes more simple, easy, fast, robust, cheap .. by Claire Tinel and @LamartheBaptis1:
Routine surveillance of kidney allograft rejection using a fully automated urinary CXCL9 and CXCL10 immunoassay medrxiv.org/content/10.1101/…
